Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus. N Engl J Med. 2022 03 17; 386(11):1034-1045.
View in:
PubMed
subject areas
Adaptor Proteins, Signal Transducing
Adult
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Ikaros Transcription Factor
Lupus Erythematosus, Systemic
Male
Middle Aged
Morpholines
Phthalimides
Piperidones
Severity of Illness Index
Ubiquitin-Protein Ligases
authors with profiles
Joan Merrill